Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION [Phase 1]

View source ↗

Summary

Phase 1 trial update on the safety of cultured allogeneic umbilical cord-derived mesenchymal stem cells for non-arteritic anterior ischemic optic neuropathy (NA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Non-arteritic Anterior Ischemic Optic Neuropathy
• Optic Atrophy
• Retinitis Pigmentosa
• Traumatic Optic Neuropathy

Drugs mentioned

• Cultured allogeneic umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Eye Diseases, Retinitis Pigmentosa | Phase 1 | Status: RECRUITING